Loading...
Loading...
Analysts at Credit Suisse upgraded Cubist Pharmaceuticals
CBST from “neutral” to “outperform.” The target price for Cubist Pharmaceuticals has been raised from $56 to $69. Cubist's shares closed at $57.00 yesterday.
Analysts at Benchmark upgraded Open Text
OTEX from “hold” to “buy.” The target price for Open Text is set to $85. Open Text's shares closed at $67.46 yesterday.
Analysts at Piper Jaffray upgraded Questcor Pharmaceuticals
QCOR from “neutral” to “overweight.” The target price for Questcor Pharmaceuticals has been raised from $41 to $74. Questcor's shares closed at $51.91 yesterday.
Analysts at JP Morgan upgraded Compass Minerals International
CMP from “underweight” to “neutral” The target price for Compass Minerals International has been raised from $65 to $66. Compass Minerals International's shares closed at $73.06 yesterday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in